Accept Cookies?
Provided by OpenGlobal E-commerce

Please wait while your page loads ...

FARAFARA Cure FA

Combined Therapy with Idebenone and Deferiprone in Patients with Friedreich's Ataxia

Iron chelators are a new therapeutical approach for patients with Friedreich's ataxia, on the basis that oxidative cell damage that occurs in these patients is due to the increasing deposits of mitochondrial iron pools. The objective of the study was to evaluate the effects of the combined therapy of idebenone and low oral doses of deferiprone on the neurological signs and cardiac function parameters.

Combined Therapy with Idebenone and Deferiprone in Patients with Friedreich's Ataxia


About the Author

Jen Farmer

Jen Farmer

Executive Director

SHARE

FacebookTwitterLinkedinShare on Google+
Family A.jpg

 

Archived in
  Scientific News


 

 

Tagged in
FARA Scientific News